Thermo Fisher Licenses ActivX Protein Profiling Tech | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has licensed technology from ActivX Biosciences that it plans to use to develop new mass spectrometry analysis and sample enrichment tools.

The Activity-Based Protein Profiling (ABPP) technology that Thermo Fisher licensed can be used for accurate and broad activity-based profiling of several enzyme families in any biological samples, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.